Effect of Salt Restriction on Renin Activation
Launched by TURKISH SOCIETY OF HYPERTENSION AND RENAL DISEASES · Jun 22, 2012
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
The present study is carried out with the subjects who are chosen among the nursing home residents in İzmir. The subjects were randomized to 2 groups and while one of these groups had low salt diet (50mmol), the other group had normal salt diet (250mmol) for 3 weeks. Subjects had normal salt diet in their daily routine life for the following 2 weeks. According to crossover nature of the study, the group that had normal salt diet at the first 3 weeks of study had low salt diet at the last 3 weeks of the study. The other group that had low salt diet had the normal salt diet at the last 3 week...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects who are 50 years and older
- • Subjects whose systolic blood pressure is ≥ 140 mmHg
- • Subjects whose diastolic blood pressure is ≥ 90 mmHg
- • Subjects who is normal weighted defined as body mass index \< 25 or who is obese defined as body mass index \> 30
- • Subjects who have intellectual capacity to adapt diets and 24 hour urine collection
- • Informed about the study and consented to include the study
- Exclusion Criteria:
- • Known heart failure
- • Known renal failure
- • Known chronic liver disease
- • Antihypertensive drug use
- • nonsteroidal anti inflammatory (NSAI) drug use
About Turkish Society Of Hypertension And Renal Diseases
The Turkish Society of Hypertension and Renal Diseases is a leading clinical trial sponsor dedicated to advancing research and improving patient outcomes in the fields of hypertension and renal health. Comprising a network of experts, healthcare professionals, and researchers, the Society fosters innovative studies that address critical challenges in cardiovascular and renal medicine. Through collaborative efforts and evidence-based practices, the Society aims to enhance clinical guidelines, promote awareness, and contribute to the development of effective therapeutic interventions, ultimately improving the quality of care for patients with hypertension and renal disorders in Turkey and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mustafa Arici, Prof.
Principal Investigator
Hacettepe University Faculty of Medicine Department of Nephrology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials